gadolinium dtpa has been researched along with rhodamine 123 in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (rhodamine 123) | Trials (rhodamine 123) | Recent Studies (post-2010) (rhodamine 123) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 1,760 | 10 | 424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelperina, S; Hübner, F; Köberle, V; Korf, HW; Korkusuz, H; Kreuter, J; Piiper, A; Pleli, T; Schmithals, C; Terfort, A; Vogl, TJ; Waidmann, O; Watcharin, W; Zeuzem, S | 1 |
1 other study(ies) available for gadolinium dtpa and rhodamine 123
| Article | Year |
|---|---|
Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging.
Topics: Animals; Carcinoma, Hepatocellular; Cell Survival; Contrast Media; Ethylenediamines; Excipients; Gadolinium DTPA; Genes, myc; Humans; Liver; Liver Neoplasms; Macrophages, Peritoneal; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Nanoparticles; Particle Size; Polyethylene Glycols; Rhodamine 123; Serum Albumin; Tissue Distribution; Transforming Growth Factor alpha | 2015 |